Recherche
-
Authors' Reply to Cohen et al.'s Comment on "Central Demyelinating Diseases after Vaccination Against Hepatitis B Virus: A Disproportionality Analysis within the VAERS Database"
(Drug Safety. vol. 41, n° 12, pp. 1429-1430, 2018-12)Article de revue -
Safety of hydroxychloroquine and darunavir or lopinavir in COVID-19 infection
(The Journal of Antimicrobial Chemotherapy. vol. 76, n° 2, pp. 482-486, 2021-01-19)Article de revue -
Atropinic (anticholinergic) burden in antipsychotic-treated patients
(Fundamental and Clinical Pharmacology. vol. 1, pp. 114-119, 2018-02)Article de revue -
Hepatitis B vaccination and central demyelination - History, description and observed/expected analyses of 624 cases reported to the French pharmacovigilance over a 20-year period
(Vaccine. vol. 37, n° 15, pp. 2142-2148, 2019-04-03)Article de revue -
A history of pharmacoepidemiology
(Thérapie. vol. 74, n° 2, pp. 175-179, 2019)Article de revue -
COVID-19: Association Between Increase of Behavioral and Psychological Symptoms of Dementia During Lockdown and Caregivers’ Poor Mental Health
(Journal of Alzheimer's disease. pp. 1-9, 2021-02-23)Article de revue -
Anticholinergic Activity of Psychotropic Drugs and Cognitive Impairment Among Participants Aged 45 and Over: The CONSTANCES Study
(Drug Safety, 2021-02-11)Article de revue -
Social deprivation is associated with poor kidney transplantation outcome in children
(Kidney International. vol. 96, n° 3, pp. 769-776, 2019-09)Article de revue -
Secondary Stroke Prevention: A Population-Based Cohort Study on Anticoagulation and Antiplatelet Treatments, and the Risk of Death or Recurrence
(Clinical Pharmacology and Therapeutics. vol. 107, n° 2, pp. 443-451, 2020)Article de revue -
Reduced dose of rivaroxaban and dabigatran vs. vitamin K antagonists in very elderly patients with atrial fibrillation in a nationwide cohort study
(EP-Europace. vol. 22, n° 2, pp. 205-215, 2020)Article de revue